Medication info

Rabeprazole Sodium 20 mg Tablets

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›20mg / 1 tablet
Manufacturer / importer
Ilhwa Co., Ltd.
Appearance
Pale yellow, round enteric-coated tablet
Packaging
28 tablets/box [(14 tablets/PTP × 2)]
Approval status
Active

MFDS item code 201802723 · Approved 2018.06.29 · Insurance code 640903660

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcers (including eradication therapy), and Zollinger-Ellison syndrome
Who takes it
Adults · Children
Adult dose
Gastric ulcer, duodenal ulcer The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. The usual treatment duration is up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI, proton pump inhibitor), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, administration of 20 mg twice daily is limited to patients with confirmed severe mucosal damage. Symptomatic relief of gastroesophageal reflux disease Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, subsequent symptoms may be controlled using on-demand therapy with 10 mg once daily as needed. Long-term maintenance treatment of gastroesophageal reflux disease Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication Patients infected with Helicobacter pylori should receive eradication therapy. It is recommended that this medicine 20 mg be administered in combination with clarithromycin 500 mg and amoxicillin 1 g twice daily for 7 days. Zollinger-Ellison syndrome The recommended initial dose for adults is 60 mg once daily. The dosage may be adjusted up to 120 mg daily according to the individual patient's needs. Doses up to 100 mg may be administered once daily, while the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this medicine for up to 1 year. Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. Elderly patients Administer with caution, as hepatic function is often reduced.
Child dose
Safety in children has not been established.

Ingredients

Manufacturer
Ilhwa Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcers (including eradication therapy), and Zollinger-Ellison syndrome

  • Gastric ulcers
  • duodenal ulcers
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • symptoms of gastroesophageal reflux disease
  • gastrointestinal ulcers
  • Zollinger-Ellison syndrome
View approved original text

This medication is effective for the treatment of gastric ulcers and duodenal ulcers, and is also used for erosive and ulcerative gastroesophageal reflux disease. It helps alleviate the symptoms of gastroesophageal reflux disease and aids in long-term management. For patients with gastrointestinal ulcers caused by Helicobacter pylori infection, it enhances treatment efficacy in combination with antibiotics. It is also helpful for the treatment of Zollinger-Ellison syndrome, which occurs infrequently. Thus, it is widely used for the treatment of various gastrointestinal disorders and symptom improvement.

How to take

Adult dose

Gastric ulcer, duodenal ulcer The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. The usual treatment duration is up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI, proton pump inhibitor), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, administration of 20 mg twice daily is limited to patients with confirmed severe mucosal damage. Symptomatic relief of gastroesophageal reflux disease Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, subsequent symptoms may be controlled using on-demand therapy with 10 mg once daily as needed. Long-term maintenance treatment of gastroesophageal reflux disease Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication Patients infected with Helicobacter pylori should receive eradication therapy. It is recommended that this medicine 20 mg be administered in combination with clarithromycin 500 mg and amoxicillin 1 g twice daily for 7 days. Zollinger-Ellison syndrome The recommended initial dose for adults is 60 mg once daily. The dosage may be adjusted up to 120 mg daily according to the individual patient's needs. Doses up to 100 mg may be administered once daily, while the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this medicine for up to 1 year. Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. Elderly patients Administer with caution, as hepatic function is often reduced.

Child dose

Safety in children has not been established.

Precautions

This medication should not be used by patients with allergies or hypersensitivity reactions to certain components. Women who are pregnant or breastfeeding should not take this medication. Patients with impaired liver function or elderly individuals should use this medication cautiously, and patients with a history of drug allergies should also exercise caution. If allergic symptoms such as rash or itchiness occur during treatment, discontinue use immediately. Regular blood tests and liver function tests should be conducted, and if any abnormal findings are detected, discontinue the medication and seek appropriate measures. Symptoms such as heart disease, hypertension, headaches, and dizziness may occur, so consult healthcare professionals if any unusual symptoms arise. This medication may affect the gastrointestinal tract, potentially leading to diarrhea, abdominal pain, nausea, vomiting, and loss of appetite. Neurological symptoms such as headaches, insomnia, anxiety, drowsiness, and tremors may also occur; caution is advised. Respiratory symptoms such as cough, pharyngitis, and asthma may develop, and in rare cases, severe respiratory issues such as pneumonia may occur, so report any symptoms immediately to medical personnel. Muscle pain, joint pain, skin rash, and hair loss have also been reported as skin and musculoskeletal adverse reactions. This medication may increase the risk of bone fractures, so attention to bone health is essential during long-term use. Long-term use may lower blood magnesium levels, thus magnesium supplementation and regular checks may be necessary. This medication suppresses gastric acid secretion, slightly increasing the risk of bacterial infections in the stomach; consult healthcare professionals if diarrhea persists. Caution is needed when driving or operating machinery, as drowsiness may occur. There may be interactions with other medications, especially when taken alongside antibiotics, anticoagulants, and antiviral agents, so consult a doctor or pharmacist if this applies. Do not chew or crush this medication; swallow the tablet whole.

Side effects

  • Rash
  • hives
  • itching
  • reduced red blood cells
  • reduced white blood cells
  • increased white blood cells
  • increased eosinophils
  • increased neutrophils
  • decreased lymphocytes
  • anemia
Show 161 more
  • purpura
  • lymphadenopathy
  • hypochromic anemia
  • pancytopenia
  • agranulocytosis
  • thrombocytopenia
  • hemolytic anemia
  • elevated ALT
  • elevated AST
  • elevated ALP
  • elevated γ-GTP
  • elevated LDH
  • elevated total bilirubin
  • fulminant hepatitis
  • liver dysfunction
  • jaundice
  • hypertension
  • myocardial infarction
  • abnormal electrocardiogram
  • migraine
  • syncope
  • angina
  • heart block
  • palpitations
  • bradycardia
  • tachycardia
  • pulmonary embolism
  • supraventricular tachycardia
  • thrombophlebitis
  • vasodilation
  • prolonged QTc interval
  • ventricular tachycardia
  • diarrhea
  • constipation
  • abdominal pain
  • abdominal bloating
  • dyspepsia
  • belching
  • nausea
  • rectal bleeding
  • bloody stools
  • anorexia
  • cholelithiasis
  • oral ulcer
  • dysphagia
  • gingivitis
  • cholecystitis
  • increased appetite
  • abnormal stools
  • colitis
  • esophagitis
  • glossitis
  • pancreatitis
  • proctitis
  • thirst
  • vomiting
  • lower abdominal pain
  • gastric body disorders
  • gastritis
  • stomatitis
  • dysgeusia
  • hemorrhagic diarrhea
  • cholangitis
  • duodenitis
  • gastrointestinal bleeding
  • hepatic encephalopathy
  • hepatitis
  • liver cancer
  • hepatic steatosis
  • salivary gland enlargement
  • thirst
  • headache
  • insomnia
  • anxiety
  • dizziness
  • convulsions
  • abnormal dreams
  • decreased libido
  • neuropathy
  • sensory disturbance
  • tremors
  • weakness
  • neuropathic hyperalgesia
  • drowsiness
  • vertigo
  • depression
  • agitation
  • amnesia
  • confusion
  • extrapyramidal syndrome
  • hypervolemia
  • limb weakness
  • sensory numbness
  • reduced grip strength
  • language confusion
  • staggering
  • disorientation
  • impaired spatial perception
  • hypersomnia
  • cough
  • pharyngitis
  • rhinitis
  • dyspnea
  • asthma
  • epistaxis
  • laryngitis
  • hiccups
  • hyperventilation
  • bronchitis
  • sinusitis
  • apnea
  • decreased respiration
  • interstitial pneumonia
  • myalgia
  • back pain
  • arthritis
  • leg cramps
  • bone pain
  • arthropathy
  • bursitis
  • hypertonia
  • neuralgia
  • single contraction
  • sweating
  • alopecia
  • dry skin
  • herpes zoster
  • psoriasis
  • skin discoloration
  • toxic epidermal necrolysis
  • mucous membrane syndrome
  • erythema multiforme
  • cataract
  • amblyopia
  • glaucoma
  • dry eyes
  • abnormal vision
  • tinnitus
  • otitis media
  • corneal opacity
  • blurriness
  • double vision
  • hearing loss
  • eye pain
  • retinal degeneration
  • strabismus
  • proteinuria
  • cystitis
  • frequency of urination
  • dysmenorrhea
  • urinary difficulty
  • nephrolithiasis
  • uterine bleeding
  • polyuria
  • gynecomastia
  • elevated thyroid-stimulating hormone
  • visual impairment
  • fractures
  • Clostridium difficile diarrhea
  • systemic lupus erythematosus
  • discoid lupus erythematosus

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to protect it from air and moisture. It is recommended to keep the storage temperature between 1 and 30 degrees Celsius. This will help maintain the medication's effectiveness and safety.

Appearance and packaging

Appearance

Pale yellow, round enteric-coated tablet

Package unit

28 tablets/box [(14 tablets/PTP × 2)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.